Literature DB >> 18253865

Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese.

Jian-Tao Bian1, Hua-Lu Zhao, Zhen-Xin Zhang, Xiu-Hua Bi, Jun-Wu Zhang.   

Abstract

Several lines of evidence support a role of oxidative stress in the pathology of Alzheimer's disease (AD). NAD(P)H:quinone oxidoreductase 1 (NQO1) catalyzes the two-electron reduction of quinones, preventing their participation in redox cycling and subsequent generation of reactive oxygen species. We examined association between the NQO1 C609T gene polymorphism and sporadic AD in a Chinese population comprising 311 AD patients and 330 controls. Our results showed a higher T-allele frequency in the AD cases compared with the controls. The difference was close to but did not reach statistically significant level [p = 0.059; odds ratio (OR) T versus C = 1.236; 95% confidence interval (95% CI), 0.992-1.540]. A significantly low C/C genotype frequency in the AD cases compared with the controls was detected (p = 0.025; OR C/C versus C/T + T/T = 0.674; 95% CI, 1.049-2.098) and APOE epsilon4 status analysis revealed significant difference in the APOE epsilon4 non-carriers (p = 0.036; OR = 0.633; 95% CI, 1.027-2.427). In the > or =65 years samples, significantly low C/C frequency in the AD cases in comparison with the controls was observed in the APOE epsilon4 non-carriers (p = 0.045; OR = 0.595; 95% CI, 1.010-2.794). These results indicated that the C/C genotype had a possible protective effect against AD development, and the T allele might be a weak risk factor for late onset AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253865     DOI: 10.1007/s12031-008-9036-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

1.  NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.

Authors:  M J Lafuente; X Casterad; M Trias; C Ascaso; R Molina; A Ballesta; S Zheng; J K Wiencke; A Lafuente
Journal:  Carcinogenesis       Date:  2000-10       Impact factor: 4.944

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease.

Authors:  Y Wang; K Santa-Cruz; C DeCarli; J A Johnson
Journal:  Neurobiol Aging       Date:  2000 Jul-Aug       Impact factor: 4.673

6.  Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia.

Authors:  Claire Infante-Rivard; Jeroen K Vermunt; Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2007-03-01       Impact factor: 4.897

7.  [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].

Authors:  Qiu-lan Ma; Jing-fang Yang; Ming Shao; Xiu-min Dong; Biao Chen
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-12-25

8.  Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease.

Authors:  Karen S SantaCruz; Eugenia Yazlovitskaya; Julie Collins; Jeff Johnson; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

View more
  5 in total

1.  E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.

Authors:  Peter Tsvetkov; Yaarit Adamovich; Evan Elliott; Yosef Shaul
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

Review 2.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.

Authors:  Albena T Dinkova-Kostova; Paul Talalay
Journal:  Arch Biochem Biophys       Date:  2010-03-31       Impact factor: 4.013

3.  DNA methylation changes in the placenta are associated with fetal manganese exposure.

Authors:  Jennifer Z J Maccani; Devin C Koestler; E Andrés Houseman; David A Armstrong; Carmen J Marsit; Karl T Kelsey
Journal:  Reprod Toxicol       Date:  2015-05-15       Impact factor: 3.143

4.  CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation.

Authors:  Hyo Jeong Kim; Min Zheng; Seul-Ki Kim; Jung Jee Cho; Chang Ho Shin; Yeonsoo Joe; Hun Taeg Chung
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

Review 5.  A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases.

Authors:  Dong-Hoon Hyun; Jaewang Lee
Journal:  Antioxidants (Basel)       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.